{"id":{"repo_id":"mtu","oai_identifier":"oai:digitalcommons.mtu.edu:etdr-2094"},"canonical_url":"https://search.ndltd.org/etd/mtu/oai:digitalcommons.mtu.edu:etdr-2094","repository":{"repo_id":"mtu","name":"Michigan Technological University","base_url":"https://digitalcommons.mtu.edu/do/oai/"},"display":{"title":"A Characterization of Colorectal Carcinoma In Patients From The Upper Peninsula of Michigan","abstract":"As the third most commonly diagnosed malignancy and second leading cause of cancer-related death, colorectal cancer remains a major global healthcare concern. Despite numerous studies to elucidate the mutations involved in tumorigenesis and assist with the prognostic stratification of patients, individual outcomes and therapeutic responses remain unpredictable. In this study, we performed a retrospective analysis of the clinical and pathological features of colorectal cancers diagnosed in the Upper Peninsula of Michigan. We then characterized the frequency and diversity of six molecular markers (MMR, BRAF, NRAS, KRAS, PIK3CA, PD-L1) in matched samples belonging to 120 patients in our cohort and correlated the findings with cancer registry data. PCR-based assays were performed to identify point mutations in the RAS, RAF and PIK3CA pathways using zinc formalin-fixed, paraffin-embedded blocks belonging to the patients in our cohort. Additionally, immunohistochemical stains were prepared to assess DNA mismatch repair protein expression and PD-L1 status in the tumor cells. Individual mutations were correlated with the clinical -pathological features of CRC in patients. We noted a higher frequency of primary tumors arising in the proximal colon, as well as a potential prognostic value in KRAS and PIK3CA mutation testing. We believe this is the first population-based study to characterize and correlate mutations with clinicopathological variables in colorectal cancer patients from the Upper Peninsula of Michigan. The findings presented here provide additional insight regarding the tumor microenvironment at various stages of disease and may lead to more effective patient management strategies as well as the development of new companion diagnostics.","abstract_html":"As the third most commonly diagnosed malignancy and second leading cause of cancer-related death, colorectal cancer remains a major global healthcare concern. Despite numerous studies to elucidate the mutations involved in tumorigenesis and assist with the prognostic stratification of patients, individual outcomes and therapeutic responses remain unpredictable. In this study, we performed a retrospective analysis of the clinical and pathological features of colorectal cancers diagnosed in the Upper Peninsula of Michigan. We then characterized the frequency and diversity of six molecular markers (MMR, BRAF, NRAS, KRAS, PIK3CA, PD-L1) in matched samples belonging to 120 patients in our cohort and correlated the findings with cancer registry data. PCR-based assays were performed to identify point mutations in the RAS, RAF and PIK3CA pathways using zinc formalin-fixed, paraffin-embedded blocks belonging to the patients in our cohort. Additionally, immunohistochemical stains were prepared to assess DNA mismatch repair protein expression and PD-L1 status in the tumor cells. Individual mutations were correlated with the clinical -pathological features of CRC in patients. We noted a higher frequency of primary tumors arising in the proximal colon, as well as a potential prognostic value in KRAS and PIK3CA mutation testing. We believe this is the first population-based study to characterize and correlate mutations with clinicopathological variables in colorectal cancer patients from the Upper Peninsula of Michigan. The findings presented here provide additional insight regarding the tumor microenvironment at various stages of disease and may lead to more effective patient management strategies as well as the development of new companion diagnostics.","abstract_has_math":false,"creators":["Bammert, Cathy"],"institution":null,"degree_name":"Doctor of Philosophy in Biological Sciences (PhD)","degree_level":"Open Access Dissertation","degree_discipline":"Department of Biological Sciences","degree_department":null,"school":null,"contributors":["Lanrong Bi","Jingfang Ju"],"advisors":[],"committee_chairs":[],"committee_members":["Chandrashekhar Joshi","Mark Tang","Feng Zhao"],"year":null,"date_issued":"","date_published":null,"updated_at":"2026-11-19T08:17:59Z","subjects":["Colon Cancer","Population Study","Mutation analysis","clinicopathological","Medicine and Health Sciences"],"languages":[],"rights":[],"rights_urls":[],"identifier_entries":[{"key":"dc:identifier","label":"Identifier","values":["https://digitalcommons.mtu.edu/etdr/925"],"render_values":[{"text":"https://digitalcommons.mtu.edu/etdr/925","href":"https://digitalcommons.mtu.edu/etdr/925","code":true}]}],"person_identifier_entries":[]},"links":{"outbound_url":"https://doi.org/10.37099/mtu.dc.etdr/925","outbound_label":"DOI","outbound_source":"dc:identifier","record_url":"https://doi.org/10.37099/mtu.dc.etdr/925","record_label":"Repository record","record_kind":"doi","record_source":"dc:identifier","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://digitalcommons.mtu.edu/do/oai/?verb=GetRecord&metadataPrefix=oai_etdms&identifier=oai%3Adigitalcommons.mtu.edu%3Aetdr-2094","prefix":"oai_etdms"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Lanrong Bi","Jingfang Ju"]},{"key":"dc:contributor.committeemember","label":"Committee Member","values":["Chandrashekhar Joshi","Mark Tang","Feng Zhao"]},{"key":"dc:creator","label":"Author","values":["Bammert, Cathy"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.available","label":"Dc Date Available","values":["2020-12-14T08:00:00Z"]},{"key":"dc:date.created","label":"Dc Date Created","values":["2019-01-01T08:00:00Z"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Department of Biological Sciences"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Open Access Dissertation"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Doctor of Philosophy in Biological Sciences (PhD)"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Colon Cancer","Population Study","Mutation analysis","clinicopathological","Medicine and Health Sciences"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["10.37099/mtu.dc.etdr/925","https://digitalcommons.mtu.edu/etdr/925"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["As the third most commonly diagnosed malignancy and second leading cause of cancer-related death, colorectal cancer remains a major global healthcare concern. Despite numerous studies to elucidate the mutations involved in tumorigenesis and assist with the prognostic stratification of patients, individual outcomes and therapeutic responses remain unpredictable. In this study, we performed a retrospective analysis of the clinical and pathological features of colorectal cancers diagnosed in the Upper Peninsula of Michigan. We then characterized the frequency and diversity of six molecular markers (MMR, BRAF, NRAS, KRAS, PIK3CA, PD-L1) in matched samples belonging to 120 patients in our cohort and correlated the findings with cancer registry data. PCR-based assays were performed to identify point mutations in the RAS, RAF and PIK3CA pathways using zinc formalin-fixed, paraffin-embedded blocks belonging to the patients in our cohort. Additionally, immunohistochemical stains were prepared to assess DNA mismatch repair protein expression and PD-L1 status in the tumor cells. Individual mutations were correlated with the clinical -pathological features of CRC in patients. We noted a higher frequency of primary tumors arising in the proximal colon, as well as a potential prognostic value in KRAS and PIK3CA mutation testing. We believe this is the first population-based study to characterize and correlate mutations with clinicopathological variables in colorectal cancer patients from the Upper Peninsula of Michigan. The findings presented here provide additional insight regarding the tumor microenvironment at various stages of disease and may lead to more effective patient management strategies as well as the development of new companion diagnostics."]},{"key":"dc:title","label":"Title","values":["A Characterization of Colorectal Carcinoma In Patients From The Upper Peninsula of Michigan"]}]}],"canonical_facts":{"dc:contributor":["Lanrong Bi","Jingfang Ju"],"dc:contributor.committeemember":["Chandrashekhar Joshi","Mark Tang","Feng Zhao"],"dc:creator":["Bammert, Cathy"],"dc:date.available":["2020-12-14T08:00:00Z"],"dc:date.created":["2019-01-01T08:00:00Z"],"dc:description.abstract":["As the third most commonly diagnosed malignancy and second leading cause of cancer-related death, colorectal cancer remains a major global healthcare concern. Despite numerous studies to elucidate the mutations involved in tumorigenesis and assist with the prognostic stratification of patients, individual outcomes and therapeutic responses remain unpredictable. In this study, we performed a retrospective analysis of the clinical and pathological features of colorectal cancers diagnosed in the Upper Peninsula of Michigan. We then characterized the frequency and diversity of six molecular markers (MMR, BRAF, NRAS, KRAS, PIK3CA, PD-L1) in matched samples belonging to 120 patients in our cohort and correlated the findings with cancer registry data. PCR-based assays were performed to identify point mutations in the RAS, RAF and PIK3CA pathways using zinc formalin-fixed, paraffin-embedded blocks belonging to the patients in our cohort. Additionally, immunohistochemical stains were prepared to assess DNA mismatch repair protein expression and PD-L1 status in the tumor cells. Individual mutations were correlated with the clinical -pathological features of CRC in patients. We noted a higher frequency of primary tumors arising in the proximal colon, as well as a potential prognostic value in KRAS and PIK3CA mutation testing. We believe this is the first population-based study to characterize and correlate mutations with clinicopathological variables in colorectal cancer patients from the Upper Peninsula of Michigan. The findings presented here provide additional insight regarding the tumor microenvironment at various stages of disease and may lead to more effective patient management strategies as well as the development of new companion diagnostics."],"dc:identifier":["10.37099/mtu.dc.etdr/925","https://digitalcommons.mtu.edu/etdr/925"],"dc:subject":["Colon Cancer","Population Study","Mutation analysis","clinicopathological","Medicine and Health Sciences"],"dc:title":["A Characterization of Colorectal Carcinoma In Patients From The Upper Peninsula of Michigan"],"thesis:degree_discipline":["Department of Biological Sciences"],"thesis:degree_level":["Open Access Dissertation"],"thesis:degree_name":["Doctor of Philosophy in Biological Sciences (PhD)"]},"updated_at":"2026-11-19T08:17:59Z"}